Program

Here you can download the program as PDF.

WEDNESDAY, DECEMBER 10, 2025

7:30 - 10:00 PM | Social event + Dinner

THURSDAY, DECEMBER 11, 2025

8:30 - 10:00 AM | Plenary Session 1: New insights into vacular biology

• Molecular drivers of atherosclerosis
• Novel regulators of endothelial function
• Cardiovascular changes driven by kidney disease

Scientific Session 1: Molecular and genetic insights for cardio-metabolic disorders

• Effects of physical exercise on RNAs in cardiovascular diseases
• Epigenetic effects of ACLY inhibition / Bempedoic acid
• Genetics of lipoprotein mediated atherogenecity

Scientific Session 2: Oxlipins - facts and myths

• Oxylipins in neuroinflammation
• Oxylipins: from detection to function
• DOACs differential regulate eicosanoids in kidney disease

Scientific Session 3: Mechanisms of atherogenesis

• Presentation from selected abstracts
• Interactions between lipid and adipocyte metabolism
• Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming
• ADAMTS and atherosclerosis

Scientific Session 4: Membrane lipids and signaling

• Presentation from selected abstracts
• Modulation of GPCR signaling by plasma lipids
• Membrane-Mediated Allosteric Action of Serotonin on a Noncognate G-Protein-Coupled Receptor
• SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor

2:30 - 4:00 PM AM | Plenary Session 2: New insights into pathogenesis of CVD

• Remnant cholesterol and atherosclerosis
• Prof. Peter Libby: Clonal Hematopoesis of Indeterminate Potential

Scientific Session 5: Sex-differences in cardio-metabolic disease

• Influence of sex and gender on the biology of atheresclerosis
• Sex and gender in clincal lipidology
• How to implement gender-sensitive medicine?

Scientific Session 6: Epigenetic aspects of cardiometabolic diseases

• Effects of nutrition on obesogenic epigentic marks
• Epigenetics link obesity to cardiometabolic diseases
• Dysregulation of DNA methylation by the environment

FRIDAY, DECEMBER 12, 2025

Scientific Session 7: Mechanisms of obesity: updates from the clinic

• Presentation from selected abstracts
• How does adipose tissue dysfunction cause cardiometabolic diseases
• Adipose tissue mitochondria in obesity and weight loss – insights from twin cohorts and intervention studies
• Learning from the extremes: Constitutional Thinness

Scientific Session 8: Priming of cardiovascular disease early in life

• Presentation from selected abstracts
• Maternal polycystic ovary syndrome and Offspring's Risk of Cardiovascular diseases
• Priming of obesity in offspring by sperm properties
• Priming of vascular disease during early-life

Scientific Session 9: Insigths into new approaches to lipid lowering

• Presentation from selected abstracts
• New lipid drugs in clinical development
• Challenges and opportunities in Lp(a) analysis
• Health economics of lipid lowering therapies

Scientific Session 10: From big data to diagnostics in lipid disorders and related diseases

• Presentation from selected abstracts
• Lipidomics in circulating vascular cells driving clotting
• Multi-omics in acute and chronic coronary syndrome
• Mitochondrial omics

1:00 - 2:20 PM | Plenary Session 3: Thromboinflammatin in CVD

• Platelet receptors and thrombo-inflammation
• Immunothrombosis in myocardial infarction
• Type-1 interferon signaling and metabolism

Scientific Session 11: Patient stratification

• Polygenic risk scores in ischemic heart disease
• Cluster Analyses in metabolic dysfunction and steatotic liver disease
• New subtypes of statin-intolerance